🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,469

Quick answer

1,469 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 10081658

    Truncated HIV envelope proteins (ENV), methods and compositions related thereto

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10080718

    Method of treating ear infections

    Try This First, Inc. · Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10080745

    Piericidin bacterial inhibitors

    The Regents of the University of California Santa Cruz · Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10081669

    Therapy for filovirus infection

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10076545

    Pharmaceutically compatible method for purifying intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10064862

    Antiviral axin stabilizer

    The Board of Regents for Oklahoma State University · Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10064858

    Methods and compositions for treating bacterial infections with iron chelators

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10040826

    Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens

    The United States of America as represented by the Secretary of the Army · Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10035845

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10035844

    Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10034929

    RNA interference functions as an antiviral immunity in mammals

    The Regents of the University of California · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10034936

    Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10005833

    Methods of treating inflammation associated airway diseases and viral infections

    The Board of Regents of the University of Texas System · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10004751

    Compositions and methods for treating Dengue virus infection

    The Regents of the University of California · Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10000522

    Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

    Ligand Pharmaceuticals Incorporated · Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9993660

    Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections

    The United States of America as represented by the Secretary of Navy · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9987377

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9982261

    Antisense antiviral compounds and methods for treating a filovirus infection

    Sarepta Therapeutics, Inc. · Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9974796

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9968653

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9969777

    Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)

    The Pirbright Institute · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9963478

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9956282

    Bacterial compositions and methods of use thereof for treatment of immune system disorders

    Seres Therapeutics, Inc. · Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9951014

    Mammalian and bacterial nitric oxide synthase inhibitors

    Northwestern University · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9950986

    Oils having antibacterial activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9951118

    Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors

    The Regents of the University of California · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9951097

    Antibacterial compounds targeting isoprenoid biosynthesis

    The Regents of the University of California · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9938236

    Antiviral agents against HBV infection

    ARBUTUS BIOPHARMA CORPORATION · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9937191

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9932543

    Bacterial spore compositions for industrial uses

    Envera, LLC · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9932391

    Proteins with repetitive bacterial-IG-like (Big) domains present in Leptospira species

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9932564

    Recombinant isfahan viral vectors

    The Board of Regents of the University of Texas System · Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9918989

    Combination therapies for malaria

    The Regents of the University of California · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9907796

    Methods of treating tumoral diseases, or bacterial or viral infections

    Inhibikase Therapeutics, Inc. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9896509

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9890176

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9890362

    Compositions, methods and uses for inducing viral growth

    Takeda Vaccines, Inc. · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9878026

    Infectious plasmodium sporozoites grown in vitro

    Sanaria Inc. · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9878033

    Immunogenic peptides for treatment of herpes simplex virus infection and conditions

    The Regents of the University of California · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9877956

    Antiviral compounds and methods of use thereof

    TRANA DISCOVERY, INC. · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9878043

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9867785

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9850468

    Infectious hepatitis E virus genotype 3 recombinants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9844598

    Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9839684

    Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

    BIOVAXIM LIMITED · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9833437

    Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure

    The United States of America as represented by the Secretary of the Army · Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9808458

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9802949

    Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,469 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.